Related Experiment Videos
[Peripheral cholesterol embolism in a percutaneous coronary angioplasty procedure. A case report]
V Climent1, R Alfonso, V Mainar
1Servicios de Cardiología y Dermatología, Hospital General Universitario de Alicante. Vcliment@coma.es
Insights
Cholesterol embolism is a rare complication after cardiac procedures. This case highlights potential triggers like anticoagulation and antiplatelet therapy.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Cholesterol embolism is a rare but serious complication following invasive cardiovascular procedures.
- Cardiac catheterization, including percutaneous angioplasty and stent implantation, carries a risk of embolic events.
Observation:
- A patient developed cholesterol embolism in the lower extremities post-percutaneous angioplasty and elective stent implantation.
- The clinical presentation involved embolic phenomena in the extremities.
Findings:
- The patient's cholesterol embolism was potentially precipitated by concurrent anticoagulation with heparin and intense antiplatelet therapy.
- The clinical course following the diagnosis was favorable.
Implications:
- This case underscores the importance of recognizing cholesterol embolism as a potential complication of interventional cardiology procedures.
- Careful consideration of anticoagulation and antiplatelet regimens may be warranted in patients undergoing such interventions to mitigate embolic risk.
Abstract:
Cholesterol embolism is a rare but potentially serious complication of cardiac catheterization. We report the case of a patient who presented a cholesterol embolism in the lower extremities after percutaneous angioplasty and the elective implantation of a stent. Clinical evolution was favourable. The appearance of cholesterol embolism could have been precipitated, in this case, by anticoagulation treatment with heparin and intense antiaggregation.